title: Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.
abstract: The significance of immune reactive proteins in malignant cervical neoplasia, with particular reference to its prognostic and clinical relevance, was studied in 229 patients. All stages of the disease showed elevated levels of circulating immune complexes (CIC). Patients with stages I/IIA showed elevated levels of IgG, whereas those with stages III and IV showed depressed IgM levels. In the case of IgA, the situation was reversed: patients with advanced disease showed increased levels. Radiotherapy resulted in highly elevated levels of CIC, IgG, and IgA. However, in patients who remained disease-free after radiation treatment, levels of these proteins came down, often falling below pretreatment levels. On the other hand, patients developing recurrent disease showed sustained, high levels of CIC and IgA, with IgG as an isolated case in stage I/IIA. The present study therefore shows that although these increases were non-tumour-specific, patients with persistent elevation of CIC and IgA levels were at much greater risk of developing recurrent disease, thereby proving the merit of these substances as markers in prognosticating the course of disease in malignant cervical neoplasia.
authors.affiliation: Regional Cancer Centre, Trivandrum, India.
authors.forename: M
authors.initials: M
authors.lastname: Radhakrishna Pillai
authors.forename: P
authors.initials: P
authors.lastname: Balaram
authors.forename: N K
authors.initials: NK
authors.lastname: Hareendran
authors.forename: S
authors.initials: S
authors.lastname: Bindu
authors.forename: T
authors.initials: T
authors.lastname: Abraham
authors.forename: T K
authors.initials: TK
authors.lastname: Padmanabhan
authors.forename: M K
authors.initials: MK
authors.lastname: Nair
mesh_terms: D000936:Antigen-Antibody Complex / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D009367:Neoplasm Staging; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000473:pathology* / Q000532:radiotherapy
chemical_list: D000936:Antigen-Antibody Complex; D014408:Biomarkers, Tumor; D007136:Immunoglobulins